The use of clonotypic mass spectrometry for post-AHCT blood-based measurable residual disease monitoring in patients with light chain multiple myeloma
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
clonotypic mass spectrometry,mass spectrometry,measurable residual disease monitoring,post-ahct,blood-based
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要